© 2022 MJH Life Sciences™ and Contemporary OB/GYN. All rights reserved.
Noninvasive Prenatal Testing
FDA warns that NIPS tests may provide false results
April 27, 2022
The FDA recently issued a statement warning the public of the risks and potential false results obtained with noninvasive prenatal screening tests, noting that inappropriate usage and interpretation has resulted in improper medical decisions.
Experts call for better newborn screening to take advantage of novel therapies
February 17, 2022
Many new therapies have been developed over the past decade to treat disorders that are often present at birth and early treatment can lead to better outcomes. However, the screenings for newborns have been slow to adapt.
Prenatal genetic data sharing and privacy risks
February 04, 2022
An oral abstract presentation at SMFM’s 42nd Annual Pregnancy Meeting explored cfDNA testing and participants’ knowledge and willingness of genetic data sharing.
Michal Elovitz, MD, discusses new preterm birth data at SMFM
February 04, 2022
In this exclusive video interview, Michal Elovitz, MD, chief medical advisor at Mirvie, discusses the latest data from the RNA testing platform in predicting preterm birth at the SMFM 42nd Annual Pregnancy Meeting.
Association of prenatal ultrasonographic findings with neonatal outcomes
February 03, 2022
At the 2022 virtual SMFM conference, a poster session highlighted a study on prenatal ultrasound findings in pregnant women with SARS-CoV-2 infection.
Mirvie RNA test aims to predict pregnancy complications
January 13, 2022
Maneesh Jain, CEO and co-founder of Mirvie, a proprietary RNA platform that uses blood samples to predict pregnancy complications such as preeclampsia, sits down with Contemporary OB/GYN to discuss the potential of the test.
NIPT routinization and social pressure are major ethical concerns
September 30, 2021
The 'routinization' of noninvasive prenatal testing (NIPT) and the increasing pressure to test and/or terminate affected pregnancies are 2 major ethical concerns of NIPT.
Noninvasive prenatal screening for single-gene disorders
September 08, 2021
A study in the journal Ultrasound in Obstetrics & Gynecology1 has found that noninvasive prenatal testing (NIPT) can help in the early detection of a set of single gene disorders (SGDs), especially in the presence of either abnormal ultrasound findings or a family history.
Noninvasive prenatal testing and good motherhood
August 31, 2021
Pregnant women do not believe that noninvasive prenatal testing (NIPT) is an obligation of responsible motherhood, according to a qualitative study that investigated the impact of NIPT on women's moral beliefs about the meaning of prenatal screening.
NIPT may not be as effective for twin pregnancies
July 20, 2021
Clinicians should carefully consider using noninvasive prenatal testing (NIPT) for the screening of chromosomal abnormalities in twin pregnancies because the combined positive predictive value (PPV) is limited and the screening efficiency is not stable, according to a prospective study.